Natural Alternatives International Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 0/6

Natural Alternatives International şirketinin kazançları yıllık ortalama -23.1% oranında azalırken, Personal Products sektörünün kazançları yıllık 3.8% oranında artan oldu. Gelirler yıllık ortalama 0.1% oranında azalan oldu.

Anahtar bilgiler

-23.1%

Kazanç büyüme oranı

-23.3%

EPS büyüme oranı

Personal Products Sektör Büyümesi	8.7%
Gelir büyüme oranı	-0.1%
Özkaynak getirisi	-10.6%
Net Marj	-7.5%
Son Kazanç Güncellemesi	30 Sep 2024

Yakın geçmiş performans güncellemeleri

Recent updates

Gelir ve Gider Dağılımı

Natural Alternatives International nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.

Kazanç ve Gelir Geçmişi

DB:NA2 Gelir, gider ve kazançlar (USD Millions )
Tarih	Gelir	Kazançlar	G+A Giderleri
30 Sep 24	113	-9	16
30 Jun 24	114	-7	15
31 Mar 24	120	-3	13
31 Dec 23	128	-4	13
30 Sep 23	145	1	13
30 Jun 23	154	3	13
31 Mar 23	171	4	16
31 Dec 22	180	8	16
30 Sep 22	176	9	17
30 Jun 22	171	11	17
31 Mar 22	163	11	17
31 Dec 21	167	10	17
30 Sep 21	177	12	17
30 Jun 21	179	11	17
31 Mar 21	169	10	16
31 Dec 20	148	4	19
30 Sep 20	129	1	18
30 Jun 20	119	-2	18
31 Mar 20	114	-4	18
31 Dec 19	124	2	14
30 Sep 19	131	4	14
30 Jun 19	138	7	15
31 Mar 19	147	10	12
31 Dec 18	144	10	14
30 Sep 18	141	6	14
30 Jun 18	132	5	14
31 Mar 18	125	4	17
31 Dec 17	119	2	16
30 Sep 17	116	6	13
30 Jun 17	122	7	12
31 Mar 17	125	9	12
31 Dec 16	130	11	11
30 Sep 16	127	11	13
30 Jun 16	114	10	11
31 Mar 16	101	7	10
31 Dec 15	91	5	9
30 Sep 15	82	4	9
30 Jun 15	80	3	9
31 Mar 15	78	3	9
31 Dec 14	78	3	8
30 Sep 14	75	2	8
30 Jun 14	74	2	8
31 Mar 14	70	1	8
31 Dec 13	66	1	9

Kaliteli Kazançlar: NA2 şu anda kârlı değil.

Büyüyen Kar Marjı: NA2 şu anda kârlı değil.

Serbest Nakit Akışı ve Kazanç Analizi

Geçmiş Kazanç Büyüme Analizi

Kazanç Eğilimi: NA2 kârlı değildir ve zararlar son 5 yılda yılda 23.1% oranında artmıştır.

Büyüme Hızlandırma: NA2 'un son bir yıldaki kazanç büyümesinin 5 yıllık ortalamasıyla karşılaştırılması mümkün değil çünkü şu anda kârlı değil

Kazançlar vs. Sektör: NA2 kârlı olmadığından, geçmiş yıl kazanç büyümesinin Personal Products sektörüyle ( 10.8% ) karşılaştırılması zorlaşıyor.

Özkaynak Getirisi

Yüksek ROE: NA2 hissesi şu anda kârlı olmadığından negatif Özsermaye Getirisi'ne ( -10.61% ) sahiptir.

Natural Alternatives International Geçmiş Kazanç Performansı

Geçmiş kriter kontrolleri 0/6

Anahtar bilgiler

Yakın geçmiş performans güncellemeleri

First quarter 2025 earnings released: US$0.34 loss per share (vs US$0.12 loss in 1Q 2024)

Full year 2024 earnings released: US$1.23 loss per share (vs US$0.43 profit in FY 2023)

Second quarter 2024 earnings released: US$0.53 loss per share (vs US$0.31 profit in 2Q 2023)

Third quarter 2023 earnings released: US$0.41 loss per share (vs US$0.42 profit in 3Q 2022)

Second quarter 2023 earnings released: EPS: US$0.31 (vs US$0.30 in 2Q 2022)

First quarter 2023 earnings released: EPS: US$0.18 (vs US$0.52 in 1Q 2022)

Recent updates

First quarter 2025 earnings released: US$0.34 loss per share (vs US$0.12 loss in 1Q 2024)

Natural Alternatives International, Inc., Annual General Meeting, Dec 06, 2024

Insufficient new directors

Full year 2024 earnings released: US$1.23 loss per share (vs US$0.43 profit in FY 2023)

New minor risk - Share price stability

Natural Alternatives International Scheduled to Reopen U.S. Manufacturing Facility in California to Support Increased Production Needs

Second quarter 2024 earnings released: US$0.53 loss per share (vs US$0.31 profit in 2Q 2023)

Natural Alternatives International, Inc., Annual General Meeting, Dec 07, 2023

Natural Alternatives International, Inc. Announces Temporary Plant Closure and Employee Furloughs

Natural Alternatives International Appoints Shane Conti as New VP of Global Sales

Third quarter 2023 earnings released: US$0.41 loss per share (vs US$0.42 profit in 3Q 2022)

Second quarter 2023 earnings released: EPS: US$0.31 (vs US$0.30 in 2Q 2022)

First quarter 2023 earnings released: EPS: US$0.18 (vs US$0.52 in 1Q 2022)

Natural Alternatives International, Inc., Annual General Meeting, Dec 02, 2022

Investor sentiment deteriorated over the past week

Full year 2022 earnings released: EPS: US$1.75 (vs US$1.71 in FY 2021)

Investor sentiment improved over the past week

Third quarter 2022 earnings released: EPS: US$0.42 (vs US$0.31 in 3Q 2021)

Second quarter 2022 earnings: Revenues and EPS in line with analyst expectations

First quarter 2022 earnings released: EPS US$0.52 (vs US$0.35 in 1Q 2021)

Investor sentiment deteriorated over the past week

Natural Alternatives International, Inc. Provides Earnings Guidance for the Fiscal Year 2022

Independent Director Alan Lane has left the company

Independent Director Lee Weldon has left the company

Full year 2021 earnings released: EPS US$1.71 (vs US$0.25 loss in FY 2020)

Investor sentiment deteriorated over the past week

Investor sentiment improved over the past week

Natural Alternatives International, Inc.(NasdaqGM:NAII) dropped from Russell Microcap Growth Index

Natural Alternatives International Regains Compliance with the Applicable Nasdaq Listing Standard

Third quarter 2021 earnings released: EPS US$0.31 (vs US$0.61 loss in 3Q 2020)

Natural Alternatives International, Inc. Provides Earnings Guidance for the Fiscal Year Ending June 30, 2021

Investor sentiment deteriorated over the past week

Independent Director recently sold €135k worth of stock

Chief Financial Officer recently sold €194k worth of stock

President recently sold €297k worth of stock

Independent Director recently sold €171k worth of stock

Second quarter 2021 earnings released: EPS US$0.58 (vs US$0.07 in 2Q 2020)

New 90-day high: €11.80

New 90-day high: €9.90

New 90-day high: €8.85

Independent Director recently sold €76k worth of stock

Chairman & CEO recently sold €96k worth of stock

New 90-day high: €8.00

First quarter 2021 earnings released: EPS US$0.35

Natural Alternatives International, Inc. (Nasdaq: NAII) acquired Real Health Laboratories, Inc. (RHL).

Full year earnings released - €0.25 loss per share

New 90-day high - €6.55

New 90-day low - €5.20

Gelir ve Gider Dağılımı

Kazanç ve Gelir Geçmişi

Serbest Nakit Akışı ve Kazanç Analizi

Geçmiş Kazanç Büyüme Analizi

Özkaynak Getirisi

Varlık Getirisi

Kullanılan Sermaye Getirisi

Geçmişte güçlü performans gösteren şirketleri keşfedin